Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS Study-Reference-Cited by-同舟云学术

Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS Study

Published:2024-01 Issue: Volume:59 Page:30-38
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Valentin Birte,Arsov Christian,Ullrich Tim,Al-Monajjed Rouvier,Boschheidgen Matthias,Hadaschik Boris A.,Giganti Francesco,Giessing Markus,Lopez-Cotarelo Cristina,Esposito Irene,Antoch Gerald,Albers Peter,Radtke Jan Philipp,Schimmöller Lars

Publisher

Elsevier BV

Subject

Urology

Reference28 articles.

1. Time trends and variation in the use of active surveillance for management of low-risk prostate cancer in the US;Cooperberg;JAMA Netw Open,2023

2. Active surveillance for low-risk prostate cancer worldwide: the PRIAS study;Bul;Eur Urol,2013

3. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer;Mottet,2023

4. Compliance rates with the Prostate Cancer Research International Active Surveillance (PRIAS) protocol and disease reclassification in noncompliers;Bokhorst;Eur Urol,2015

5. Multiparametric magnetic resonance imaging alone is insufficient to detect grade reclassification in active surveillance for prostate cancer;Chu;Eur Urol,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancer;European Radiology;2024-09-13

2. PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer;European Urology;2024-09

3. Is MRI ready to replace biopsy during active surveillance?;European Radiology;2024-07-04